论文部分内容阅读
目的 Crizotinibhasbeenreportedtobeparticularlyeffectiveandtohaveacceptabletoxicityinadvancedanaplasticlymphomakinase(ALK)-positivenon-small-celllungcancer(NSCLC).Inthisstudy,weanalyzedtheefficacyandtolerabilityofcrizotinibinthetreatmentof72ChinesepatientswithALK-positive,advancedNSCLC.